Biotech Values

[tinkershaw]

Dew,

I have a question. With the Genzyme thing, maybe I missed something, but if the FDA is taking such a strict stand that the same drug, produced by the same company, with the same process, but only at a different facility is treated as a "biosimilar" and not a "biogeneric" then what hope does such a drug, even if identical in every way hope to have when it is manufactured not only in a different facility, but also by a different company to be a true biogeneric?

Thanks.

Tinker